Patents by Inventor Christopher Coxon

Christopher Coxon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10906932
    Abstract: A method for preparing a cyclic peptide, derivative or analogue thereof is described. The method comprises contacting a peptide, derivative or analogue thereof with a fluoro-heteroaromatic compound to cyclise the peptide, derivative or analogue thereof.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: February 2, 2021
    Assignee: The University of Durham
    Inventors: Steven Cobb, Christopher Coxon, Graham Sandford
  • Patent number: 10040819
    Abstract: A method for chemically modifying a peptide, derivative or analogue thereof is described. The method comprises contacting a peptide, derivative or analogue thereof with a fluoro-heteroaromatic compound to activate the peptide, derivative or analogue thereof. The activated peptide, derivative or analogue thereof is then contacted with a nucleophile or base to create a chemically modified peptide, derivative or analogue thereof.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: August 7, 2018
    Assignee: The University of Durham
    Inventors: Steven Cobb, Christopher Coxon, Graham Sandford
  • Publication number: 20170204134
    Abstract: A method for preparing a cyclic peptide, derivative or analogue thereof is described. The method comprises contacting a peptide, derivative or analogue thereof with a fluoro-heteroaromatic compound to cyclise the peptide, derivative or analogue thereof.
    Type: Application
    Filed: May 28, 2015
    Publication date: July 20, 2017
    Inventors: Steven Cobb, Christopher Coxon, Graham Sandford
  • Publication number: 20170081360
    Abstract: A method for chemically modifying a peptide, derivative or analogue thereof is described. The method comprises contacting a peptide, derivative or analogue thereof with a fluoro-heteroaromatic compound to activate the peptide, derivative or analogue thereof. The activated peptide, derivative or analogue thereof is then contacted with a nucleophile or base to create a chemically modified peptide, derivative or analogue thereof.
    Type: Application
    Filed: May 28, 2015
    Publication date: March 23, 2017
    Inventors: Steven Cobb, Christopher Coxon, Graham Sandford